UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test

Journal of clinical microbiology, 2020-07, Vol.58 (8)

2020

Volltextzugriff (PDF)

Relapsed/Refractory ETP‐ALL Successfully Treated With Venetoclax and Nelarabine as a Bridge to Allogeneic Stem Cell Transplant

HemaSphere, 2020-06, Vol.4 (3), p.e379-n/a

2020

Volltextzugriff (PDF)

A large, refractory nosocomial outbreak of Klebsiella pneumoniae carbapenemase-producing Escherichia coli demonstrates carbapenemase gene outbreaks involving sink sites require novel approaches to infection control

Antimicrobial agents and chemotherapy, 2018-12, Vol.62 (12)

2018

Volltextzugriff (PDF)

Relapsed/refractory ETP-all successfully treated with novel combination therapy venetoclax with nelarabine prior to allogeneic stem cell transplant

Pathology, 2020-02, Vol.52, p.S115-S116

2020

Volltextzugriff (PDF)

Australasian Trends in Allogeneic Stem Cell Transplantation for Myelofibrosis in the Molecular Era: A Retrospective Analysis from the Australasian Bone Marrow Transplant Recipient Registry

Biology of blood and marrow transplantation, 2020-12, Vol.26 (12), p.2252-2261

2020

Volltextzugriff (PDF)

Diagnosis and management of endothelial disorders following haematopoietic stem cell transplantation

Internal medicine journal, 2023-12, Vol.53 (12), p.2162-2174

2023

Volltextzugriff (PDF)

Absence of integrated bone marrow biopsy reporting significantly impacts diagnosis of acute myeloid leukaemia – a retrospective study

Pathology, 2024-02, Vol.56, p.S107-S108

2024

Volltextzugriff (PDF)

ANZTCT practice statement: sinusoidal obstruction syndrome/veno‐occlusive disease diagnosis and management

Internal medicine journal, 2024-07

2024

Volltextzugriff (PDF)

Real-world SARS CoV-2 testing in Northern England during the first wave of the COVID-19 pandemic

The Journal of infection, 2021-07, Vol.83 (1), p.84-91

2021

Volltextzugriff (PDF)

Multicentre evaluation of a real-time PCR assay to detect genes encoding clinically relevant carbapenemases in cultured bacteria

International journal of antimicrobial agents, 2016-02, Vol.47 (2), p.151-154

2016

Volltextzugriff (PDF)

An Overview of SARS-CoV-2 Molecular Diagnostics in Europe

Clinics in laboratory medicine, 2022-06, Vol.42 (2), p.161

2022

Volltextzugriff (PDF)

An Update of Australasian Trends in Allogeneic Stem Cell Transplantation for Myelofibrosis in the Molecular Era

Blood, 2019-11, Vol.134 (Supplement_1), p.5719-5719

2019

Volltextzugriff (PDF)

Genomic Epidemiology of Complex, Multispecies, Plasmid-Borne bla KPC Carbapenemase in Enterobacterales in the United Kingdom from 2009 to 2014

Antimicrobial agents and chemotherapy, 2020-04, Vol.64 (5)

2020

Volltextzugriff (PDF)

Evaluation of the artus® Prep&Amp UM RT-PCR for detection of SARS-CoV-2 from nasopharyngeal swabs without prior nucleic acid eluate extraction

Journal of clinical virology plus, 2022-08, Vol.2 (3), p.100098-100098, Article 100098

2022

Volltextzugriff (PDF)

Evaluation of the artus® Prep Amp UM RT-PCR for detection of SARS-CoV-2 from nasopharyngeal swabs without prior nucleic acid eluate extraction

Journal of clinical virology plus, 2022-08, Vol.2 (3), p.100098

2022

Volltextzugriff (PDF)

Clostridium Difficile Infection in Haematology Patients Significantly Increases Length of Stay; A Case Control Study

Blood, 2015-12, Vol.126 (23), p.2108-2108

2015

Volltextzugriff (PDF)

Bone Targeted Therapies

Resistance to Targeted Therapies in Multiple Myeloma, 2021, Vol.22, p.105-127

2021

Volltextzugriff (PDF)

Relapsed/Refractory ETP-ALL Successfully Treated With Venetoclax and Nelarabine as a Bridge to Allogeneic Stem Cell Transplant

HemaSphere, 2020, Vol.4 (3), p.e379-e379

2020

Volltextzugriff (PDF)

Abstract 1428: Allogeneic CRISPR/Cas9 gene-edited CAR-T cells targeting CD33 show potent preclinical activity against AML cells

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.1428-1428

2019

Volltextzugriff (PDF)

The cost impact of outreach testing and treatment for hepatitis C in an urban Drug Treatment Unit

Liver international, 2017-03, Vol.37 (3), p.345-353

2017

Volltextzugriff (PDF)

Is antenatal screening for hepatitis C virus cost-effective? A decade’s experience at a London centre

Journal of hepatology, 2015-10, Vol.63 (4), p.797-804

2015

Volltextzugriff (PDF)

Abstract 1537: CD70 knockout: A novel approach to augment CAR-T cell function

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1537-1537

2021

Volltextzugriff (PDF)

Assessment of priority tobacco additives per the requirements of the EU Tobacco Products Directive (2014/40/EU): Part 3, Smoking behavior and plasma nicotine pharmacokinetics

Regulatory toxicology and pharmacology, 2019-06, Vol.104, p.29-38

2019

Volltextzugriff (PDF)

A clinician’s guide to the cost and health benefits of hepatitis C cure assessed from the individual patient perspective

European journal of gastroenterology & hepatology, 2017-02, Vol.29 (2), p.208-214

2017

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(27)

Publikationsform

Sprache

Englisch
(29)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test

Relapsed/Refractory ETP‐ALL Successfully Treated With Venetoclax and Nelarabine as a Bridge to Allogeneic Stem Cell Transplant

A large, refractory nosocomial outbreak of Klebsiella pneumoniae carbapenemase-producing Escherichia coli demonstrates carbapenemase gene outbreaks involving sink sites require novel approaches to infection control

Relapsed/refractory ETP-all successfully treated with novel combination therapy venetoclax with nelarabine prior to allogeneic stem cell transplant

Australasian Trends in Allogeneic Stem Cell Transplantation for Myelofibrosis in the Molecular Era: A Retrospective Analysis from the Australasian Bone Marrow Transplant Recipient Registry

Diagnosis and management of endothelial disorders following haematopoietic stem cell transplantation

Absence of integrated bone marrow biopsy reporting significantly impacts diagnosis of acute myeloid leukaemia – a retrospective study

ANZTCT practice statement: sinusoidal obstruction syndrome/veno‐occlusive disease diagnosis and management

Carbapenem-resistant Enterobacteriaceae dispersal from sinks is linked to drain position and drainage rates in a laboratory model system

Real-world SARS CoV-2 testing in Northern England during the first wave of the COVID-19 pandemic

Multicentre evaluation of a real-time PCR assay to detect genes encoding clinically relevant carbapenemases in cultured bacteria

An Overview of SARS-CoV-2 Molecular Diagnostics in Europe

An Update of Australasian Trends in Allogeneic Stem Cell Transplantation for Myelofibrosis in the Molecular Era

Genomic Epidemiology of Complex, Multispecies, Plasmid-Borne bla KPC Carbapenemase in Enterobacterales in the United Kingdom from 2009 to 2014

Evaluation of the artus® Prep&Amp UM RT-PCR for detection of SARS-CoV-2 from nasopharyngeal swabs without prior nucleic acid eluate extraction

Evaluation of the artus® Prep Amp UM RT-PCR for detection of SARS-CoV-2 from nasopharyngeal swabs without prior nucleic acid eluate extraction

Clostridium Difficile Infection in Haematology Patients Significantly Increases Length of Stay; A Case Control Study

Bone Targeted Therapies

Relapsed/Refractory ETP-ALL Successfully Treated With Venetoclax and Nelarabine as a Bridge to Allogeneic Stem Cell Transplant

Abstract 1428: Allogeneic CRISPR/Cas9 gene-edited CAR-T cells targeting CD33 show potent preclinical activity against AML cells

The cost impact of outreach testing and treatment for hepatitis C in an urban Drug Treatment Unit

Is antenatal screening for hepatitis C virus cost-effective? A decade’s experience at a London centre

Abstract 1537: CD70 knockout: A novel approach to augment CAR-T cell function

Assessment of priority tobacco additives per the requirements of the EU Tobacco Products Directive (2014/40/EU): Part 3, Smoking behavior and plasma nicotine pharmacokinetics

A clinician’s guide to the cost and health benefits of hepatitis C cure assessed from the individual patient perspective

Suchergebnisse filtern